Publications by authors named "Maria E Sheean"

Claim this Profile
F
From guideline to practice: three years of ICH S11 insights and recommendations.
Diana Tavares, Hsiao-Tzu Chien, Maria Elzbieta Sheean, Peter Theunissen, Peter van Meer

Front Med (Lausanne)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining Satisfactory Methods of Treatment in Rare Diseases When Evaluating Significant Benefit-The EU Regulator's Perspective.
Maria E Sheean, Frauke Naumann-Winter, Giuseppe Capovilla, Maria Elisabeth Kalland, Eva Malikova

Front Med (Lausanne)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory Standards in Orphan Medicinal Product Designation in the EU.
Stelios Tsigkos, Segundo Mariz, Maria Elzbieta Sheean, Kristina Larsson, Armando Magrelli

Front Med (Lausanne)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical data supporting orphan medicinal product designations in the area of rare infectious diseases.
Maria E Sheean, Eva Malikova, Dinah Duarte, Giuseppe Capovilla, Laura Fregonese

Drug Discov Today· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining orphan conditions in the context of the European orphan regulation: challenges and evolution.
Daniel J O'Connor, Maria E Sheean, Matthias P Hofer, Stelios Tsigkos, Segundo Mariz

Nat Rev Drug Discov· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuregulin 3 promotes excitatory synapse formation on hippocampal interneurons.
Thomas Müller, Stephanie Braud, René Jüttner, Birgit C Voigt, Katharina Paulick, Maria E Sheean

EMBO J· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing rarity in the context of orphan medicinal product designation in the European Union.
Stelios Tsigkos, Matthias Philipp Hofer, Maria Elzbieta Sheean, Segundo Mariz, Kristina Larsson

Drug Discov Today· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical data supporting orphan medicinal product designations: lessons from rare neurological conditions.
Maria E Sheean, Violeta Stoyanova-Beninska, Giuseppe Capovilla, Dinah Duarte, Matthias P Hofer

Drug Discov Today· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of MAPK overrides the termination of myelin growth and replaces Nrg1/ErbB3 signals during Schwann cell development and myelination.
Maria E Sheean, Erik McShane, Cyril Cheret, Jan Walcher, Thomas Müller

Genes Dev· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis